Key Updates and Clinical Implications for Multiple sclerosis Diagnosis: 2024 Revisions to McDonald Criteria

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from Wish List failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Key Updates and Clinical Implications for Multiple sclerosis Diagnosis: 2024 Revisions to McDonald Criteria

Listen for free

View show details

About this listen

Welcome to the BeewellwithMS Research Paper of the October Month! In this video, we delve into the 2024 Revisions of the McDonald Criteria for the diagnosis of Multiple Sclerosis (MS). We'll provide a concise, up-to-date summary of the key changes, including new diagnostic criteria, the importance of dissemination in space and time, advanced MRI markers like the central vein sign (CVS) and paramagnetic rim lesions (PRL), and the role of CSF biomarkers such as Oligoclonal bands (OCB) and kappa free light chain (kFLC) index. This detailed review aims to help clinicians, patients, and anyone interested in MS to better understand the updated diagnostic process, improve early detection, and ensure timely and appropriate treatment. Stay tuned for more insights into MS symptoms, MS treatment, disease modifying treatments, MS diet, exercises, and smoldering MS.

00:00 Introduction to the 2024 McDonald Criteria for MS Diagnosis
00:27 Understanding Multiple Sclerosis and the Importance of Early Diagnosis
00:40 Key Updates in the 2024 McDonald Criteria
01:35 Advanced MRI Markers in MS Diagnosis
02:21 Role of CSF Biomarkers in MS Diagnosis
03:05 Diagnostic Workflow and Differential Diagnosis
03:56 Clinical and Patient Implications of the 2024 McDonald Criteria
04:19 Conclusion and Future Outlook

Become a supporter of this podcast: https://www.spreaker.com/podcast/beewellwithms-podcast-by-dr-agne-straukiene--5762905/support.

No reviews yet